期刊文献+

人诱导多能干细胞体外扩增生成红系集落并构建红系祖细胞株的研究

In vitro proliferation of human induced pluripotent stem cells into erythroid colony and establishment of a stable erythroid progenitor cell line
下载PDF
导出
摘要 目的将人诱导多能干细胞(hi PSCs)分化成为红系祖细胞并构建稳定的红系祖细胞株。方法采用与滋养层细胞共培养的方式,添加10 ng/m L的TPO、5 U/m L的EPO、25 ng/m L的SCF、5 ng/m L的Flt-3、20 ng/m L的IL-3的诱导因子,诱导hi PSCs分化成为红系集落,构建稳定的红系祖细胞株;倒置显微镜观察获得的细胞株形态,瑞氏染色并计数,MTT法检测细胞活性,流式细胞仪检测细胞表面标志物。结果 hi PSCs诱导构建的红系祖细胞株遗传性状稳定并可长期传代,细胞呈集落样生长,外观上与正常红系祖细胞无差异。分类计数构建的红系祖细胞株比例(%):P0与P5代细胞为84.90±4.93 vs 72.20±6.24(P<0.05);流式检测,hi PSCs诱导构建的红系祖细胞株细胞表面标志物CD235a阳性率(%)表达:P0与P5代细胞为3.02±0.75 vs 5.87±0.37(P<0.05)。结论诱导hi PSCs生成的红系祖细胞株在表面标志继承性和遗传性状方面都是稳定的。 Objective To induce differentiation of human induced pluripotent stem cells( hi PSCs) into erythroid progenitor cells and to establish a stable erythroid progenitor cell line. Methods The hi PSCs were co-cultured with trophoblast,and supplemented with 10 ng / m L of TPO,5U / m L of EPO,25 ng / m L of SCF,5ng / m L of Flt-3,and 20 ng / m L of IL-3 to induce differentiation of the hi PSCs into erythroid colony and to construct a stable erythroid progenitor cell line. Cell morphology was observed by inverted microscopy. The number of cells were counted after Wright staining. Cell activity was determined by MTT assay. Last,cell surface markers were determined by flow cytometry. Results The hi PSC-derived erythroid progenitor cells were stable and can be passed on for a long period. The cells grew in colonies,and were morphologically identical to normal erythroid progenitor cells. The rate of erythroid progenitor-like cells were 84. 90 ± 4. 93% and 72. 20± 6. 24%,respectively,in the P0 and P5 generations( P〈 0. 05). Flow cytometry indicated that the positive rates of cell surface CD235 a were 5. 87 ± 0. 37 and 3. 02 ± 0. 75,respectively,in the P0 and P5 generations of induced erythroid progenitor cells( P 〈0. 05). Conclusion Both the genetic traits and cell surface markers of the hi PSC-induced erythroid progenitor cell line are stable.
出处 《中国输血杂志》 CAS 北大核心 2015年第5期493-497,共5页 Chinese Journal of Blood Transfusion
基金 国家自然科学基金(81270649)
关键词 人诱导多能干细胞 红系集落 红系祖细胞株 滋养层细胞共培养 体外扩增 诱导因子 human induced pluripotent stem cells erythroid colony erythroid progenitor cell line trophoblast co-culture in vitro amplification inducing factor
  • 相关文献

参考文献27

  • 1Spitzer TR, De)" BR, Chen YB, et al. The expanding frontier of hematopoiefic troll transplantation. Cytometry B Clin Cytom,2012, 82(5) : 271-279.
  • 2Copelan EA. Hematopoiefic stem-cell transplantation. N Engl J Meal,2006, 354(17) : 1813-1826.
  • 3Daley GQ. The promise and perils of stem cell therapeutics. Cell Stem Ce11,2012, 10(6) : 740-749.
  • 4ChristeUe M, Luc D, H61ne L. Red blood cells from induced plu- ripotent stem cells: hurdles and developments. Hematology,2011, 18(4) : 249 253.
  • 5Raya A, Rodrlguez-Piza I, Guenechea G. Disease-corrected haema- topoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature,2009, 460(7251 ) : 53-61.
  • 6Choi KD Vodyanik MA, Slukvin II. Generation of mature human myelomonocytie cells through expansion and differentiation of pluri- potent stem cell-derived lin-CD34 + CD43 * CIM5 + progenitors J Clin Invest,2009, 119 (9) : 2818-2829.
  • 7Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin Science,2007, 318(5858) : 1920-1923.
  • 8Ebihara Y, Ma F, Tsuji K. Generation of red blood calls from hu- man embryonic/induced pluripotent stem cells for blood transfu- sion. Int J Hematol,2012, 95 (6) : 610 -616.
  • 9Mills JA, Paluru P, Weiss MJ, et al. Hematopoietie differentiation of pluripotent stem cells in culture. Methods Mol Biol. 2014, 1185 (6) :181-194.
  • 10雷慧芬,范娅涵,孟强,尹智平,陆华,蒋天伦,赵树铭.体外构建人巨核祖细胞/胃癌细胞融合体生成血小板的研究[J].中国输血杂志,2011,24(4):294-298. 被引量:3

二级参考文献21

  • 1莫文健,毛平,何秋山,应逸,朱志刚,许艳丽,杜庆华.两步法脐血巨核细胞体外扩增的研究[J].中国输血杂志,2005,18(5):381-383. 被引量:1
  • 2方建培,夏婷,陈国华,吴燕峰,徐宏贵,魏菁,黄绍良.脐血和外周血来源的巨核细胞体外扩增差异的研究[J].中华儿科杂志,2006,44(11):869-872. 被引量:3
  • 3Matsunaga T, Tanaka I, Kobune M, et aL Ex vivo large scale gener- ation of human platelets from cord blood CD34^+ cells. Stern Cells, 2006,24(12) :2877-2887.
  • 4Sullenbarger B, Bahng JH, Gruner R, et al. Prolonged continuous in vitro human platelet production using three dimensional scaf- folds. Exp Hematol,2009,37 ( 1 ) : 101-110.
  • 5Nishi H, Nakada T, Kyo S, et al. Hypoxia-inducible factor 1 medi- ate upregulation of telomerase (hTERT). Mol Cell Biol, 2004,24 ( 13 ) :6076-6083.
  • 6Figueiredo C,Goudeva L,Hom PA,et al. Generation of HLA-defi- cient platelets from hematopoietic progenitor. Transfusion ,2010,50 (8) :1690-1701.
  • 7Apiratmateekul N, Phunpae P, Kasinrerk W, et al. A modified hy- bfidoma technique for production of monoclonal antibodies having desired isotypes. Cytotechnology ,2009,60 ( 1-3 ) :45-51.
  • 8Isabelle I. Salles, Tim Thijs, Christine Brunaud, et al. Human plate- lets produced in nonobese diabetic/severe combined immunodefi- cient (NOD/SCID)mice upon transplantation of human cord blood CD34^+ cells are functionally active in an ex vivo flow model of thrombosis. Blood,2009,114(24) :5044-5051.
  • 9Takayama N, Nishikii H, Usui J, et aL Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progeni- tots. Blood ,2008,111 ( 11 ) :5298-5306.
  • 10Sullenbarger B, Bahng JH, Gruner R,et al. Prolonged continuous in vitro human platelet production using three dimensional scaf- folds. Exp Hematol,2009,37 ( 1 ) : 101-110.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部